Cancer chemotherapeutics - angiogenesis agents: October 1999 - March 2000

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.6, 2000-06, pp. : 767-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October 2000 – March 2001

By Connell Richard D Beebe Jean S

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 7, 2001-07 ,pp. : 1171-1203

Informa Healthcare

Access to resources Recommend Favorite

Patent focus on cancer chemotherapeutics. IV Angiogenesis agents: April 2001 - August 2001

By Connell Richard D Beebe Jean S

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1919-1945

Informa Healthcare

Access to resources Recommend Favorite

Patent focus on cancer chemotherapeutics V. Angiogenesis agents: September 2001 – August 2002

By Connell Richard D

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1763-1782

Informa Healthcare

Access to resources Recommend Favorite

Patent focus on agents affecting cardiovascular and renal functions November 1999 - March 2000

By Lemmens-Gruber R.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 5, 2000-05 ,pp. : 533-548

Informa Healthcare

Access to resources Recommend Favorite

Patent focus on antiparasitic agents: May - October 1999

By Hudson A.T.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 2, 2000-02 ,pp. : 153-163

Informa Healthcare

Access to resources Recommend Favorite